Allergy Therapeutics plc (FRA:HHU)

Allergy Therapeutics Statistics

Total Valuation

FRA:HHU has a market cap or net worth of EUR 843.92 million. The enterprise value is 898.54 million.

Market Cap	843.92M
Enterprise Value	898.54M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	6.14B
Shares Outstanding	n/a
Shares Change (YoY)	+27.33%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	3.39%
Float	325.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.14
PB Ratio	-25.66
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-19.19
EV / Sales	14.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.55

Financial Position

The company has a current ratio of 1.28

Current Ratio	1.28
Quick Ratio	0.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.92
Interest Coverage	-4.47

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-26.58%
Return on Invested Capital (ROIC)	-149.09%
Return on Capital Employed (ROCE)	-70.59%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	109,956
Profits Per Employee	-80,168
Employee Count	584
Asset Turnover	0.82
Inventory Turnover	1.93

Taxes

In the past 12 months, FRA:HHU has paid 1.09 million in taxes.

Income Tax	1.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +85.51% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+85.51%
50-Day Moving Average	0.12
200-Day Moving Average	0.09
Relative Strength Index (RSI)	57.03
Average Volume (20 Days)	659

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:HHU had revenue of EUR 64.21 million and -46.82 million in losses. Loss per share was -0.01.

Revenue	64.21M
Gross Profit	34.18M
Operating Income	-33.23M
Pretax Income	-45.73M
Net Income	-46.82M
EBITDA	-30.54M
EBIT	-33.23M
Loss Per Share	-0.01

Balance Sheet

The company has 14.92 million in cash and 70.10 million in debt, with a net cash position of -55.18 million.

Cash & Cash Equivalents	14.92M
Total Debt	70.10M
Net Cash	-55.18M
Net Cash Per Share	n/a
Equity (Book Value)	-32.89M
Book Value Per Share	-0.01
Working Capital	8.73M

Cash Flow

In the last 12 months, operating cash flow was -32.79 million and capital expenditures -3.81 million, giving a free cash flow of -36.60 million.

Operating Cash Flow	-32.79M
Capital Expenditures	-3.81M
Free Cash Flow	-36.60M
FCF Per Share	n/a

Margins

Gross margin is 53.23%, with operating and profit margins of -51.75% and -72.91%.

Gross Margin	53.23%
Operating Margin	-51.75%
Pretax Margin	-71.22%
Profit Margin	-72.91%
EBITDA Margin	-47.56%
EBIT Margin	-51.75%
FCF Margin	n/a

Dividends & Yields

FRA:HHU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.33%
Shareholder Yield	-27.33%
Earnings Yield	-5.55%
FCF Yield	-4.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:HHU has an Altman Z-Score of -3.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.55
Piotroski F-Score	2